Cutaneous Drug Reactions Associated With Nivolumab Treatment for Metastatic Non-Small- Cell Lung Cancer (Nsclc) Case Report

Adrián Pablo Huñis, Dra Gabriela Nacuzzi, Martín Pitzzu, Dra Melisa Huñis, Laura Juffé and Sergio Lepoivre
Additional contact information
Sergio Lepoivre: Buenos Aires Oncology Center (COBA), Argentina

Cancer Therapy & Oncology International Journal, 2018, vol. 10, issue 2, 20-22

Abstract: We present the clinical case of a patient diagnosed with non-small cell lung cancer (NSCLC) under treatment with Nivolumab. The patient develops a severe dermatological condition, which is why a biopsy of one of the lesions is performed, the diagnosis being: “Cutaneous Drug Reactions†. We review the literature, discuss the mechanisms by which these clinical presentations can occur and present this patient as a contribution to the medical literature on the adverse effects by this molecule.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555782.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555782.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:10:y:2018:i:2:p:20-22

DOI: 10.19080/CTOIJ.2018.10.555782

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().